Takeda H - Search Results

1

Review article: Long-term Helicobacter pylori infection--from gastritis to gastric cancer.

Asaka M, Kudo M, Kato M, Sugiyama T, Takeda H. Asaka M, et al. Among authors: takeda h. Aliment Pharmacol Ther. 1998 Feb;12 Suppl 1:9-15. doi: 10.1111/j.1365-2036.1998.00007.x. Aliment Pharmacol Ther. 1998. PMID: 9701000 Review.

2

[Helicobacter pylori infection in peptic ulcer disease].

Takeda H, Asaka M. Takeda H, et al. Nihon Rinsho. 2002 Feb;60 Suppl 2:13-8. Nihon Rinsho. 2002. PMID: 11979764 Review. Japanese. No abstract available.

3

[Long-term follow-up after H. pylori eradication].

Kato M, Shimizu Y, Rinan Z, Takeda H, Asaka M. Kato M, et al. Among authors: takeda h. Nihon Rinsho. 2005 Nov;63 Suppl 11:491-4. Nihon Rinsho. 2005. PMID: 16363586 Review. Japanese. No abstract available.

4

Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection.

Kato M, Asaka M, Ono S, Nakagawa M, Nakagawa S, Shimizu Y, Chuma M, Kawakami H, Komatsu Y, Hige S, Takeda H. Kato M, et al. Among authors: takeda h. J Gastroenterol. 2007 Jan;42 Suppl 17:16-20. doi: 10.1007/s00535-006-1928-5. J Gastroenterol. 2007. PMID: 17238020 Free article. Review.

5

High-dose ecabet sodium improves the eradication rate of helicobacter pylori in dual therapy with lansoprazole and amoxicillin.

Kagaya H, Kato M, Komatsu Y, Mizushima T, Sukegawa M, Nishikawa K, Hokari K, Takeda H, Sugiyama T, Asaka M. Kagaya H, et al. Among authors: takeda h. Aliment Pharmacol Ther. 2000 Nov;14(11):1523-7. doi: 10.1046/j.1365-2036.2000.00852.x. Aliment Pharmacol Ther. 2000. PMID: 11069325 Clinical Trial.

6

[Recent guidelines for the management of Helicobacter pylori infection].

Kato M, Hokari K, Kagaya H, Takeda H, Sugiyama T, Asaka M. Kato M, et al. Among authors: takeda h. Nihon Rinsho. 2001 Feb;59(2):246-51. Nihon Rinsho. 2001. PMID: 11218393 Review. Japanese.

7

Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers?

Sugiyama T, Nishikawa K, Komatsu Y, Ishizuka J, Mizushima T, Kumagai A, Kato M, Saito N, Takeda H, Asaka M, Freston JW. Sugiyama T, et al. Among authors: takeda h. Dig Dis Sci. 2001 Feb;46(2):307-10. doi: 10.1023/a:1005600831851. Dig Dis Sci. 2001. PMID: 11281179

8

Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism.

Hokari K, Sugiyama T, Kato M, Saito M, Miyagishima T, Kudo M, Nishikawa K, Ishizuka J, Komatsu Y, Mizushima T, Kagaya H, Hige S, Takeda H, Asaka M. Hokari K, et al. Among authors: takeda h. Aliment Pharmacol Ther. 2001 Sep;15(9):1479-84. doi: 10.1046/j.1365-2036.2001.01063.x. Aliment Pharmacol Ther. 2001. PMID: 11552922 Clinical Trial.

9

Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study.

Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham DY. Asaka M, et al. Among authors: takeda h. Helicobacter. 2001 Dec;6(4):294-9. doi: 10.1046/j.1523-5378.2001.00042.x. Helicobacter. 2001. PMID: 11843961

10

The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance.

Perez Aldana L, Kato M, Nakagawa S, Kawarasaki M, Nagasako T, Mizushima T, Oda H, Kodaira J, Shimizu Y, Komatsu Y, Zheng R, Takeda H, Sugiyama T, Asaka M. Perez Aldana L, et al. Among authors: takeda h. Helicobacter. 2002 Oct;7(5):306-9. doi: 10.1046/j.1523-5378.2002.00096.x. Helicobacter. 2002. PMID: 12390210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,521 results

Search Page

Filters